Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

GNMX vs. IHI: which is better?

Bottom line

GNMX vs IHI: the short answer

GNMX (Corgi Genomics & Precision Medicine ETF) and IHI (iShares U.S. Medical Devices ETF) are both etfs.

Updated Nov 19, 2026

GNMX vs IHI side by side

GNMXIHI
TypeETFETF
Fund familyCorgi Genomics & Precision MedicineiShares
CategoryHealth Care SectorHealth Care Sector
Expense ratio—0.37%
Annual cost per $10k—$37
10-yr cost on $10k (prospectus)—$468
Max front loadNoneNone
12b-1 fee—0%
1-yr return—+6.9%
5-yr return (annualized)—+3.1%
10-yr return (annualized)—+12.2%
Best quarter—+17.6%
Worst quarter—−17.2%
Net assets (fund)—$3.0B
Number of holdings—50
Portfolio turnover—12%
Returns as of—Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Holdings overlap

GNMX and IHI share none of their top holdings.

GNMX top 10

    IHI top 10

    1. Abbott Laboratories — 16.93%
    2. Intuitive Surgical, Inc. — 15.09%
    3. Stryker Corporation — 11.64%
    4. Edwards Lifesciences Corporation — 4.75%
    5. Becton, Dickinson And Company — 4.63%
    6. Ge Healthcare Technologies Inc. — 4.51%
    7. Medtronic Public Limited Company — 4.40%
    8. Resmed Inc. — 4.38%
    9. Idexx Laboratories, Inc. — 4.27%
    10. Dexcom, Inc. — 4.02%

    FAQ

    What is the difference between GNMX and IHI?
    GNMX (Corgi Genomics & Precision Medicine ETF) and IHI (iShares U.S. Medical Devices ETF) are both etfs.
    Should I own both GNMX and IHI?
    Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

    Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.